Repository logo
 
Publication

Functional genomics in familial dyslipidaemia

dc.contributor.authorGraça, Rafael
dc.date.accessioned2019-02-18T17:13:44Z
dc.date.available2019-02-18T17:13:44Z
dc.date.issued2018-12
dc.description.abstractFamilial Hypercholesterolemia (FH) is a genetic autosomal dominant disorder characterized clinically by high LDL plasma concentrations from birth causing premature atherosclerosis and coronary heart disease (CHD). The genetic diagnosis is made by finding a functional mutation in one of 3 genes: LDLR (≈90%), APOB (<8%) and PCSK9 (<3%). FH has a frequency between 1/200 and 1/500 for heterozygous and 1/160 000 to 1/1 000 000 for homozygous in most European countries. However, only 40% of the patients enrolled in the Portuguese FH Study carry a putative pathogenic mutation. Other concern point is that less than 15% of the LDLR variants found worldwide in patients with FH diagnosis have functional evidence supporting its pathogenicity.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/5870
dc.language.isoengpt_PT
dc.publisherInstituto Nacional de Saúde Doutor Ricardo Jorge, IPpt_PT
dc.subjectFamilial Hypercholesterolemiapt_PT
dc.subjectDyslipidaemiapt_PT
dc.subjectDoenças Cardio e Cérebro-vascularespt_PT
dc.titleFunctional genomics in familial dyslipidaemiapt_PT
dc.typelecture
dspace.entity.typePublication
oaire.citation.conferencePlaceLisboa, Portugalpt_PT
oaire.citation.titlePalestras do DPSPDNT, INSA, 14 dezembro 2018pt_PT
rcaap.rightsclosedAccesspt_PT
rcaap.typelecturept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Functional genomics in familial dyslipidaemia.pdf
Size:
701.23 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: